References
- DoaneTLBurdaCThe unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapyChem Soc Rev20124172885291122286540
- WagnerVDullaartABockAKZweckAThe emerging nanomedicine landscapeNat Biotechnol200624101211121717033654
- MaXWilliamsROPolymeric nanomedicines for poorly soluble drugs in oral delivery systems: an updateInt J Pharm Investig20184816175
- HoangNHLimCSimTOhKTKtOTriblock copolymers for nano-sized drug delivery systemsJ Pharm Investig20174712735
- MoghimiSMHunterACMurrayJCLong-circulating and target-specific nanoparticles: theory to practicePharmacol Rev200153228331811356986
- SonG-HLeeB-JChoC-WMechanisms of drug release from advanced drug formulations such as polymeric-based drug-delivery systems and lipid nanoparticlesJ Pharm Investig2017474287296
- UhrichKECannizzaroSMLangerRSShakesheffKMPolymeric systems for controlled drug releaseChem Rev199999113181319811749514
- DumortierGGrossiordJLAgnelyFChaumeilJCA review of poloxamer 407 pharmaceutical and pharmacological characteristicsPharm Res200623122709272817096184
- DansonSFerryDAlakhovVPhase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancerBritish Journal of Cancer200490112085209115150584
- XiongXYTamKCGanLHPolymeric nanostructures for drug delivery applications based on Pluronic copolymer systemsJ Nanosci Nanotechnol200669–102638265017048472
- HanLMGuoJZhangLJWangQSFangXLPharmacokinetics and biodistribution of polymeric micelles of paclitaxel with Pluronic P123Acta Pharmacol Sin200627674775316723095
- TorchilinVPStructure and design of polymeric surfactant-based drug delivery systemsJ Control Release2001732–313717211516494
- YunJMParkS-YoungLeeESPhysicochemical characterizations of amphiphilic block copolymers with different MWs and micelles for development of anticancer drug nanocarriersMacromol Res2012209944953
- AllenCMaysingerDEisenbergANano-engineering block copolymer aggregates for drug deliveryColloids Surf B Biointerfaces1999161–4327
- AlakhovVKlinskiELiSBlock copolymer-based formulation of doxorubicin. From cell screen to clinical trialsColloids Surf B Biointerfaces1999161–4113134
- WangYYuLHanLShaXFangXDifunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell linesInt J Pharm20073371–2637317289311
- LeeESOhYTYounYSBinary mixing of micelles using Pluronics for a nano-sized drug delivery systemColloids Surf B Biointerfaces201182119019520850281
- OhKTBronichTKKabanovAVMicellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic Pluronic block copolymersJ Control Release2004942–341142214744491
- DanhierFVromanBLecouturierNTargeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxelJ Control Release2009140216617319699245
- DanhierFLe BretonAPréatVRGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosisMol Pharm20129112961297322967287
- ZalipskySBaranyGFacile synthesis of α-hydroxy-ω−carboxymethylpolyethylene oxideJ Bioact Compat Polym199052227231
- LeeESLimCSongHTA nanosized delivery system of superparamagnetic iron oxide for tumor MR imagingInt J Pharm20124391–234234822959991
- JeongJYHongEHLeeSYBoronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetrationActa Biomater20175341442628216300
- FröhlichEThe role of surface charge in cellular uptake and cytotoxicity of medical nanoparticlesInt J Nanomedicine201275577559123144561
- HeCHuYYinLTangCYinCEffects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticlesBiomaterials201031133657366620138662
- LimCSimTHoangNHA charge-reversible nanocarrier using PEG-PLL (-g-Ce6, DMA)-PLA for photodynamic therapyInt J Nanomedicine2017126185619628883728
- ChoiYHHanH-KNanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokineticsJ Pharm Investig20184814360
- KaoC-LChaT-LKaoC-CWeekly low-dose docetaxel is an effective treatment with fewer adverse events for metastatic castration-resistant prostate cancer in Taiwanese patientsUrol Sci2015264267270
- HoangNHLimCSimTCharacterization of a triblock copolymer, poly(ethylene glycol)-polylactidepoly(ethylene glycol), with different structures for anticancer drug delivery applicationsPolym Bull201774515951609
- di TommasoCComoCGurnyRMöllerMInvestigations on the lyophilisation of MPEG-hexPLA micelle based pharmaceutical formulationsEur J Pharm Sci2010401384720184955
- XuSOlenyukBZOkamotoCTHamm-AlvarezSFTargeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advancesAdv Drug Deliv Rev201365112113823026636
- LiZHuangPZhangXRGD-conjugated dendrimer-modified gold nanorods for in vivo tumor targeting and photothermal therapyMol Pharm2010719410419891496
- YonenagaNKenjoEAsaiTRGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatmentJ Control Release2012160217718122019557
- MaedaHBharateGYDaruwallaJPolymeric drugs for efficient tumor-targeted drug delivery based on EPR-effectEur J Pharm Biopharm200971340941919070661
- FangJNakamuraHMaedaHThe EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effectAdv Drug Deliv Rev201163313615120441782
- ChoiJRustiqueEHenryMTargeting tumors with cyclic RGD-conjugated lipid nanoparticles loaded with an IR780 NIR dye: in vitro and in vivo evaluationInt J Pharm2017532267768528279737
- BaeYHParkKTargeted drug delivery to tumors: myths, reality and possibilityJ Control Release2011153319820521663778